Related Experiment Video
Updated: Jun 11, 2026

08:44
Assembly and Characterization of Polyelectrolyte Complex Micelles
Published on: March 2, 2020
Responsive polyelectrolyte complexes for triggered release of nucleic acid therapeutics
Mahmoud Soliman1, Stephanie Allen, Martyn C Davies
1School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK.
Summary
Polycations are crucial carriers for nucleic acid therapeutics, protecting them and enabling targeted release. Future polycation designs promise enhanced treatments for intractable diseases.
Area of Science:
- Biomaterials Science
- Drug Delivery
- Therapeutics Development
Background:
- Nucleic acid therapeutics offer significant potential for disease treatment.
- Effective delivery vehicles are essential to protect nucleic acids and ensure site-specific release.
- Polycations are promising candidates for nucleic acid delivery due to their complex-forming and release capabilities.
Purpose of the Study:
- To review recent advancements in polycation-based nucleic acid delivery systems.
- To explore the potential of future polycation materials for enhanced therapeutic outcomes.
- To highlight the role of polycations in treating currently untreatable diseases.
Main Methods:
- Review of recent scientific literature on polycationic carriers for nucleic acid therapeutics.
- Analysis of polyelectrolyte complex formation and dissociation mechanisms.
- Discussion of design strategies for targeted delivery and controlled release.
Main Results:
- Polycations effectively condense nucleic acids into stable complexes.
- Appropriate polycation design allows for controlled release of nucleic acids at target sites.
- Recent advances show promise for improved therapeutic efficacy.
Conclusions:
- Polycations are versatile and essential for the clinical application of nucleic acid therapeutics.
- Future developments in polycation design could lead to breakthrough treatments for various diseases.
- Targeted delivery and controlled release are key to unlocking the full potential of nucleic acid therapies.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...

